Display options
Cite
Nishi S, Zhou J, Kuo YF, et al. Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population. Mayo Clin Proc Innov Qual Outcomes. 2019;3(1):70-77doi: 10.1016/j.mayocpiqo.2018.12.003.
Nishi, S., Zhou, J., Kuo, Y. F., & Goodwin, J. S. (2019). Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population. Mayo Clinic proceedings. Innovations, quality & outcomes, 3(1), 70-77. https://doi.org/10.1016/j.mayocpiqo.2018.12.003
Nishi, Shawn, et al. "Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population." Mayo Clinic proceedings. Innovations, quality & outcomes vol. 3,1 (2019): 70-77. doi: https://doi.org/10.1016/j.mayocpiqo.2018.12.003
Nishi S, Zhou J, Kuo YF, Goodwin JS. Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population. Mayo Clin Proc Innov Qual Outcomes. 2019 Feb 26;3(1):70-77. doi: 10.1016/j.mayocpiqo.2018.12.003. eCollection 2019 Mar. PMID: 30899910; PMCID: PMC6410337.
Copy Download .nbib Format: NLM
Share it on

Mayo Clin Proc Innov Qual Outcomes. 2019 Feb 26;3(1):70-77. doi: 10.1016/j.mayocpiqo.2018.12.003. eCollection 2019 Mar.

Use of Lung Cancer Screening With Low-Dose Computed Tomography in the Medicare Population.

Mayo Clinic proceedings. Innovations, quality & outcomes

Shawn Nishi, Jie Zhou, Yong-Fang Kuo, James S Goodwin

Affiliations

  1. Department of Internal Medicine, The University of Texas Medical Branch, Galveston, TX.
  2. Division of Pulmonary Critical Care & Sleep Medicine, The University of Texas Medical Branch, Galveston, TX.
  3. Sealy Center on Aging, The University of Texas Medical Branch, Galveston, TX.

PMID: 30899910 PMCID: PMC6410337 DOI: 10.1016/j.mayocpiqo.2018.12.003

Abstract

OBJECTIVE: To describe rates of low-dose computed tomography (LDCT) and all chest computerized tomography (CT) before and after Centers for Medicare and Medicaid Services (CMS) initiated reimbursement and requirements for screening and to describe factors associated with receipt of LDCT.

PATIENTS AND METHODS: Retrospective cross-sectional study of Medicare enrollees aged 55 to 77 in Parts A and B Medicare without HMO enrollment in a 20% national sample (n=3,887,430 in 2010, 4,200,875 in 2015, and 4,145,542 in 2016). The outcomes were receipt of LDCT and any chest CT from January 1, 2010, to December 31, 2016. Other measures included enrollee demographic characteristics and diagnoses, including diagnoses of tobacco use.

RESULTS: The number of enrollees aged 55 to 77 with LDCT rose throughout 2015 and early 2016, and then plateaued. In 2016, 0.44% of enrollees, and 2.21% of those with a tobacco-use diagnosis, underwent LDCT screening. There were increases in the rate of any chest CT (LDCT or diagnostic) between January 1, 2010 and December 31, 2016, and most of this was accounted for by LDCTs.

CONCLUSIONS: Two years after CMS approval for lung cancer screening reimbursement, less than 5% of the Medicare population eligible for screening received LDCT. More work is required to identify and modify the barriers for LDCT screening.

Keywords: CMS, Center for Medicare and Medicaid Services; COPD, chronic obstructive pulmonary disease; CPT, current procedural terminology; HMO, Health Maintenance Organization; ICD-10, International Classification of Diseases Tenth Revision; ICD-9, International Classification of Diseases Ninth Revision; LDCT, low dose computed tomography; NHIS, National Health Interview Study; USPSTF, United States Preventive Services Task Force

References

  1. JAMA. 2001 Jun 6;285(21):2750-6 - PubMed
  2. Stroke. 2005 Aug;36(8):1776-81 - PubMed
  3. Prev Med. 2006 Dec;43(6):472-6 - PubMed
  4. Arch Intern Med. 2009 Apr 27;169(8):781-7 - PubMed
  5. Am J Prev Med. 2010 Dec;39(6 Suppl 1):S77-82 - PubMed
  6. N Engl J Med. 2011 Aug 4;365(5):395-409 - PubMed
  7. J Am Med Inform Assoc. 2013 Jul-Aug;20(4):652-8 - PubMed
  8. Am J Epidemiol. 2013 Sep 15;178(6):974-83 - PubMed
  9. Cancer. 2013 Nov 15;119(22):3976-83 - PubMed
  10. Ann Intern Med. 2014 Mar 4;160(5):330-8 - PubMed
  11. Am Health Drug Benefits. 2014 Aug;7(5):272-82 - PubMed
  12. Prev Med. 2015 Jan;70:83-9 - PubMed
  13. Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):664-70 - PubMed
  14. J Oncol Pract. 2015 Jul;11(4):267-72 - PubMed
  15. JAMA Oncol. 2016 Feb 11;:null - PubMed
  16. JAMA. 2016 Jun 7;315(21):2279-81 - PubMed
  17. Cancer. 2016 Aug 1;122(15):2324-31 - PubMed
  18. J Gen Intern Med. 2016 Nov;31(11):1308-1314 - PubMed
  19. Chest. 2017 Mar;151(3):572-578 - PubMed
  20. MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211 - PubMed
  21. JAMA Intern Med. 2017 Mar 1;177(3):439-441 - PubMed
  22. JAMA Oncol. 2017 Sep 1;3(9):1278-1281 - PubMed
  23. J Am Coll Radiol. 2017 Feb;14(2):166-170 - PubMed
  24. Ann Am Thorac Soc. 2017 Aug;14(8):1261-1265 - PubMed
  25. CA Cancer J Clin. 2018 Jan;68(1):7-30 - PubMed
  26. BMC Health Serv Res. 2018 Jul 5;18(1):525 - PubMed
  27. Med Care. 1998 Jan;36(1):8-27 - PubMed

Publication Types

Grant support